Company · CIK 0001285819 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
OMEROS CORP · OMER
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 9:00 pm EDT | David J. BorgesVP, Finance & CAO | 20,000 | $20.95 | $419,000 | 0 | −100% | 10b5-1 |
| Sep 22, 2026 MForm 4 → | Sep 24, 9:00 pm EDT | David J. BorgesVP, Finance & CAO | 20,000 | $9.51 | $190,150 | 10,000 | — | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Sep 1, 4:41 pm EDT | Peter B CancelmoVP, General Counsel | 50,000 | $18.59 | $929,668 | 200 | −99.6% | |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:41 pm EDT | Peter B CancelmoVP, General Counsel | 50,000 | $2.94 | $147,000 | 25,200 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 24, 9:00 pm EDT | David J. BorgesVP, Finance & CAO | 20,000 | — | — | 5,000 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:41 pm EDT | Peter B CancelmoVP, General Counsel | 50,000 | — | — | 50,000 | — |